S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Forecast, Price & News

$67.23
-1.79 (-2.59%)
(As of 10/2/2023 ET)
Compare
Today's Range
$66.83
▼
$68.86
50-Day Range
$63.36
▼
$81.53
52-Week Range
$54.66
▼
$85.62
Volume
423,487 shs
Average Volume
300,298 shs
Market Capitalization
$3.87 billion
P/E Ratio
43.10
Dividend Yield
N/A
Price Target
$87.83
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Merit Medical Systems MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
30.6% Upside
$87.83 Price Target
Short Interest
Healthy
1.77% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
1.23mentions of Merit Medical Systems in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$2.08 M Sold Last Quarter
Proj. Earnings Growth
11.81%
From $2.88 to $3.22 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.90 out of 5 stars

Medical Sector

44th out of 969 stocks

Surgical & Medical Instruments Industry

8th out of 100 stocks

See Top Rated MarketRank™ Stocks Here

MMSI stock logo

About Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Price History

MMSI Stock News Headlines

September 30, 2023 | americanbankingnews.com
Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from Needham & Company LLC
September 27, 2023 | markets.businessinsider.com
Analyst Expectations for Merit Medical Systems's Future
October 2, 2023 | Behind the Markets (Ad)
How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
September 23, 2023 | americanbankingnews.com
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of "Moderate Buy" by Brokerages
September 21, 2023 | markets.businessinsider.com
Buy Rating for Merit Medical Systems: Undervalued Potential and Strategic Growth Initiatives
September 6, 2023 | finance.yahoo.com
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
August 29, 2023 | finance.yahoo.com
Should You Be Adding Merit Medical Systems (NASDAQ:MMSI) To Your Watchlist Today?
August 29, 2023 | msn.com
Merit Medical: Soft Expectations, Capital Productivity Into FY2023 (Rating Downgrade)
October 2, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
August 28, 2023 | msn.com
Canaccord Genuity Maintains Merit Medical Systems (MMSI) Hold Recommendation
August 16, 2023 | markets.businessinsider.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Merit Medical Systems (MMSI) and Legend Biotech (LEGN)
August 16, 2023 | markets.businessinsider.com
Expert Ratings for Merit Medical Systems
August 10, 2023 | msn.com
Merit Medical (MMSI) Completes Enrollment in WRAPSODY Study
August 8, 2023 | finance.yahoo.com
Merit Medical Systems' (NASDAQ:MMSI) Returns Have Hit A Wall
August 3, 2023 | finance.yahoo.com
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
July 27, 2023 | msn.com
Needham Reiterates Merit Medical Systems (MMSI) Buy Recommendation
July 26, 2023 | msn.com
Merit Medical Systems Q2 Beat Expectations: Analysts Say China/Russia Headwinds Hamper Guidance Raise
July 25, 2023 | seekingalpha.com
Merit Medical Systems, Inc. 2023 Q2 - Results - Earnings Call Presentation
July 21, 2023 | markets.businessinsider.com
Analysts Are Bullish on Top Healthcare Stocks: CymaBay Therapeutics (CBAY), Merit Medical Systems (MMSI)
July 21, 2023 | finance.yahoo.com
Are Merit Medical Systems, Inc. (NASDAQ:MMSI) Investors Paying Above The Intrinsic Value?
July 13, 2023 | entrepreneur.com
T2 Biosystems (TTOO) vs. Merit Medical Systems (MMSI): Which Is the Better Growth Stock?
July 6, 2023 | markets.businessinsider.com
Merit Medical's Recent M&A Efforts Set To Show Early Impact In FY24: Analyst Insight
July 6, 2023 | markets.businessinsider.com
Barrington Keeps Their Buy Rating on Merit Medical Systems (MMSI)
July 6, 2023 | markets.businessinsider.com
The Latest Analyst Ratings for Merit Medical Systems
July 6, 2023 | finance.yahoo.com
Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023
July 3, 2023 | finance.yahoo.com
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock Is Going Strong: Have Financials A Role To Play?
June 26, 2023 | finance.yahoo.com
Inspire Medical (INSP) Hits 52-Week High: What's Aiding It?
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Company Calendar

Last Earnings
7/25/2023
Today
10/02/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
CIK
856982
Web
www.merit.com
Phone
(801) 253-1600
Fax
801-253-1652
Employees
6,846
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$87.83
High Stock Price Forecast
$96.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+30.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.56
Trailing P/E Ratio
43.10
Forward P/E Ratio
23.34
P/E Growth
2.08
Net Income
$74.52 million
Net Margins
7.48%
Pretax Margin
8.19%
Return on Equity
14.60%
Return on Assets
9.87%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
3.13
Quick Ratio
1.52

Sales & Book Value

Annual Sales
$1.20 billion
Price / Sales
3.23
Cash Flow
$4.25 per share
Price / Cash Flow
15.81
Book Value
$20.11 per share
Price / Book
3.34

Miscellaneous

Outstanding Shares
57,600,000
Free Float
55,469,000
Market Cap
$3.87 billion
Optionable
Optionable
Beta
0.97

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Fred P. LampropoulosMr. Fred P. Lampropoulos (Age 73)
    Founder, Chairman, CEO & Pres
    Comp: $2.8M
  • Mr. Raul Parra Jr. (Age 45)
    CPA, CFO & Treasurer
    Comp: $928.35k
  • Mr. Neil Peterson (Age 57)
    Chief Operating Officer
    Comp: $1.02M
  • Mr. Brian G. LloydMr. Brian G. Lloyd (Age 62)
    Chief Legal Officer & Corp. Sec.
    Comp: $848.66k
  • Mr. Joseph C. WrightMr. Joseph C. Wright (Age 53)
    Chief Commercial Officer
    Comp: $970.59k
  • Mr. Jason Treft
    Chief Technology Officer
  • Mr. Joseph Pierce
    Chief Information Officer
  • Sarah Comstock
    VP of Global Communications
  • JoAnne Alkire
    Exec. VP of Global Marketing & Strategy
  • Mr. Michel J. Voigt (Age 50)
    Chief HR Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MMSI Stock - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings or view top-rated stocks.

What is Merit Medical Systems' stock price forecast for 2023?

5 Wall Street analysts have issued 12 month target prices for Merit Medical Systems' stock. Their MMSI share price forecasts range from $70.00 to $96.00. On average, they expect the company's share price to reach $87.83 in the next year. This suggests a possible upside of 30.6% from the stock's current price.
View analysts price targets for MMSI or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2023?

Merit Medical Systems' stock was trading at $70.62 at the beginning of the year. Since then, MMSI stock has decreased by 4.8% and is now trading at $67.23.
View the best growth stocks for 2023 here.

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our MMSI earnings forecast.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings data on Tuesday, July, 25th. The medical instruments supplier reported $0.81 EPS for the quarter, beating the consensus estimate of $0.75 by $0.06. The medical instruments supplier had revenue of $320.06 million for the quarter, compared to analysts' expectations of $310.10 million. Merit Medical Systems had a trailing twelve-month return on equity of 14.60% and a net margin of 7.48%. The company's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 earnings per share.

What ETFs hold Merit Medical Systems' stock?

ETFs with the largest weight of Merit Medical Systems (NASDAQ:MMSI) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), Emerge EMPWR Sustainable Select Growth Equity ETF (EMGC), Invesco S&P SmallCap Momentum ETF (XSMO), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Emerge EMPWR Unified Sustainable Equity ETF (EMPW), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), SPDR S&P 600 Small Cap Growth ETF (SLYG) and iShares S&P Small-Cap 600 Growth ETF (IJT).

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its FY23 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $2.81-2.92 for the period, compared to the consensus estimate of $2.90. The company issued revenue guidance of $1.230-1.244 billion, compared to the consensus revenue estimate of $1.23 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $67.23.

How much money does Merit Medical Systems make?

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $3.87 billion and generates $1.20 billion in revenue each year. The medical instruments supplier earns $74.52 million in net income (profit) each year or $1.56 on an earnings per share basis.

How many employees does Merit Medical Systems have?

The company employs 6,846 workers across the globe.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.

This page (NASDAQ:MMSI) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -